Judith Thijs
12PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Feb 09, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy.Roselie Achten, Judith Thijs, Marlot van der Wal
|Mar 19, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis.Roselie Achten, Judith Thijs, Marlot van der Wal
|Jul 15, 2022
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.Lotte S Spekhorst, Daphne Bakker, Julia Drylewicz
|Oct 09, 2019
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.Lieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker
Pageof 2
Frequent Collaborators
12 joint publications
Marjolein S de Bruin-Weller
8 joint publications
Daphne S Bakker
5 joint publications
Julia Drylewicz
4 joint publications
Edward Knol
4 joint publications
Lieneke F M Ariëns
4 joint publications
Roselie E Achten
3 joint publications
DirkJan Hijnen
3 joint publications
Lotte Spekhorst
2 joint publications
Stefan Nierkens
2 joint publications
Marlot van der Wal
